Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542.
Jacobson JM, Israel RJ, Lowy I, Ostrow NA, Vassilatos LS, Barish M, Tran DN, Sullivan BM, Ketas TJ, O'Neill TJ, Nagashima KA, Huang W, Petropoulos CJ, Moore JP, Maddon PJ, Olson WC.
Jacobson JM, et al. Among authors: moore jp.
Antimicrob Agents Chemother. 2004 Feb;48(2):423-9. doi: 10.1128/AAC.48.2.423-429.2004.
Antimicrob Agents Chemother. 2004.
PMID: 14742190
Free PMC article.
Clinical Trial.